You are here

Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Glendale, California, 91206 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Schizophrenia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Women of nonchildbearing potential, or men, aged 18 to 55 years inclusive on study day
1. Women of nonchildbearing potential may be included if they are either surgically
sterile (hysterectomy and/or oophorectomy) or postmenopausal for ≥1 year (with a
follicle-stimulating hormone [FSH] level of ≥38 mIU/mL). Women who are surgically
sterile must provide documentation of the procedure by an operative report or
ultrasound scan. Sexually active men must agree to use a medically acceptable form of
contraception during the study and continue it for 12 weeks after test article
administration.

- Body mass index in the range of 18 to 32 kg/m2 and body weight ≥50 kg.

- Hemoglobin no lower than 0.4 g/dL, less than the lower limit of the normal range, and
white blood cell count no lower than 0.5 103/mm3, less than the lower limit of the of
the normal range at screening and day -1. Hematocrit and absolute neutrophil count
within normal range at screening and on day -1.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Women of childbearing potential.

- Presence or history of any disorder that may prevent the successful completion of the
study.

- Any unstable psychiatric condition, which may prevent the successful and safe
completion of the study in the opinion of the investigator.

NCT00781794
Pfizer
Terminated
Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now